Clinical trials show an average of 10 to 15 percent body weight reduction over 68 weeks
So, they built on it, developing a synthetic version of the hormone GLP-1 (glucagon-like peptide-1) receptor agonist
More boys were self-assessed as being pubertal (68%) compared to 52% of the girls ( p = 0.001)
However, the comparison involves more than percentages
Specifically, this peptide seemed to suppress the growth of two types of cancer cells in experimental settings: SH-SY5Y neuroblastoma cells, which are a model for studying nerve cell behavior and pathology, and U937 histiocytic lymphoma cells, which are used to study the immune system's response to cancer
Gastrointestinal side effects by the numbers The most striking difference is nausea